Rating History for Summit Therapeutics plc (SMMT) by Bernstein SocGen Group

More Stocks Rated by Bernstein SocGen Group | Latest Ratings for SMMT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/22/2026 Jeffrey Walch Maintain Underperform
(N/A)		 9.80
(7.70)		  
 		   Details